The functional roles of poly(ethylene glycol)-lipid and lysolipid in the drug retention and release from lysolipid-containing thermosensitive liposomes in vitro and in vivo
✍ Scribed by Brian Banno; Ludger M. Ickenstein; Gigi N.C. Chiu; Marcel B. Bally; Jenifer Thewalt; Elana Brief; Ellen K. Wasan
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 359 KB
- Volume
- 99
- Category
- Article
- ISSN
- 0022-3549
No coin nor oath required. For personal study only.
✦ Synopsis
Triggered release of liposomal contents following tumor accumulation and mild local heating is pursued as a means of improving the therapeutic index of chemotherapeutic drugs. Lysolipid-containing thermosensitive liposomes (LTSLs) are composed of dipalmitoylphosphatidylcholine (DPPC), the lysolipid monostearoylphosphatidylcholine (MSPC), and poly-(ethylene glycol)-conjugated distearoylphosphatidylethanolamine (DSPE-PEG 2000 ). We investigated the roles of DSPE-PEG 2000 and lysolipid in the functional performance of the LTSLdoxorubicin formulation. Varying PEG-lipid concentration (0-5 mol%) or bilayer orientation did not affect the release; however, lysolipid (0-10 mol%) had a concentration-dependent effect on drug release at 428C in vitro. Pharmacokinetics of various LTSL formulations were compared in mice with body temperature controlled at 378C. As expected, incorporation of the PEG-lipid increased doxorubicin plasma half-life; however, PEG-lipid orientation (bilayer vs. external leaflet) did not significantly improve circulation lifetime or drug retention in LTSL. Approximately 70% of lysolipid was lost within 1 h postinjection of LTSL, which could be due to interactions with the large membrane pool of the biological milieu. Considering that the present LTSL-doxorubicin formulation exhibits significant therapeutic activity when used in conjunction with mild heating, our current study provided critical insights into how the physicochemical properties of LTSL can be tailored to achieve better therapeutic activity.